<--- Back to Details
First PageDocument Content
Pharmacology / Synthes / Adverse effect / MedWatch / Medical device / Class I recall / U.S. Securities and Exchange Commission / Medicine / Health / Food and Drug Administration
Date: 2012-01-16 13:52:49
Pharmacology
Synthes
Adverse effect
MedWatch
Medical device
Class I recall
U.S. Securities and Exchange Commission
Medicine
Health
Food and Drug Administration

Microsoft Word - EN Synex II Recall Media Release.doc

Add to Reading List

Source URL: www.synthes.com

Download Document from Source Website

File Size: 26,66 KB

Share Document on Facebook

Similar Documents

Referenz-Story DePuy Synthes Der neue Europa-Hauptsitz von DePuy Synthes ist ein moderner Neubau im solothurnischen Zuchwil: Hier beschäftigt das Medizinaltechnik-Unternehmen rund 500 Mitarbeitende in der Forschung und

DocID: 1swf5 - View Document

Abteilung Drehen Synthes Bettlach GmbH

DocID: 1pXhR - View Document

Abteilung Drehen Synthes Bettlach GmbH

DocID: 1pFi2 - View Document

Abteilung Drehen Synthes Bettlach GmbH

DocID: 1p53u - View Document

Banking / Great Depression / International finance / Tax evasion / UBS / Drug development / Actelion / Synthes / Kuros

27 JuneThis report has been issued for information purposes only and is not intended to constitute investment advice. It is based on estimates and forecasts of third parties regarding revenues, earnings and busine

DocID: 1ovo8 - View Document